BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
BCRX Historical Performance
Short-Term Returns
BCRX Stock Price Trajectory (2011–2026)
As of May 8, 2026, BioCryst Pharmaceuticals, Inc. (BCRX) trades at $8.90, representing a -11.7% return over the past year. The stock has delivered a -32.2% total return over five years (-7.5% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $37.25 on March 9, 2000. From this peak, BCRX has corrected -76.1%, currently trading 13% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RARE (-21.8% 1Y), FOLD (+137.9% 1Y), and ACAD (+52.4% 1Y), BCRX has underperformed the peer group average. Compare BCRX vs RARE →
BCRX Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 8.77 | 8.94 | 8.56 | 8.90 | 5.51M | +0.79% |
| 2026-05-06 | 8.46 | 8.91 | 7.79 | 8.83 | 8.98M | -2.21% |
| 2026-05-05 | 9.21 | 9.30 | 8.94 | 9.03 | 3.05M | -1.85% |
| 2026-05-04 | 9.12 | 9.39 | 9.02 | 9.20 | 3.43M | +0.11% |
| 2026-05-01 | 9.16 | 9.33 | 9.09 | 9.19 | 2.27M | +0.33% |
| 2026-04-30 | 9.01 | 9.36 | 8.96 | 9.16 | 3.24M | +1.89% |
| 2026-04-29 | 9.02 | 9.19 | 8.82 | 8.99 | 2.98M | +1.47% |
| 2026-04-28 | 9.04 | 9.15 | 8.80 | 8.86 | 2.37M | -0.45% |
| 2026-04-27 | 8.92 | 9.20 | 8.88 | 8.90 | 3.01M | -0.45% |
| 2026-04-24 | 8.72 | 8.95 | 8.62 | 8.94 | 2.18M | +2.05% |
| 2026-04-23 | 9.02 | 9.12 | 8.70 | 8.76 | 2.31M | -2.77% |
| 2026-04-22 | 8.59 | 9.02 | 8.59 | 9.01 | 3.57M | +5.01% |
| 2026-04-21 | 9.20 | 9.27 | 8.56 | 8.58 | 4.91M | -6.64% |
| 2026-04-20 | 9.40 | 9.43 | 9.09 | 9.19 | 2.93M | -3.26% |
| 2026-04-17 | 9.62 | 9.67 | 9.43 | 9.50 | 3.54M | -0.21% |
| 2026-04-16 | 9.45 | 9.57 | 9.32 | 9.52 | 4.29M | +0.85% |
| 2026-04-15 | 9.75 | 9.77 | 9.38 | 9.44 | 4.84M | -2.38% |
| 2026-04-14 | 9.49 | 9.68 | 9.37 | 9.67 | 2.58M | +2.76% |
| 2026-04-13 | 9.56 | 9.56 | 9.34 | 9.41 | 3.15M | -1.57% |
| 2026-04-10 | 9.89 | 9.90 | 9.49 | 9.56 | 4.34M | -3.34% |
| 2026-04-09 | 9.76 | 9.98 | 9.71 | 9.89 | 4.45M | +1.12% |
| 2026-04-08 | 9.65 | 9.92 | 9.64 | 9.78 | 6.79M | +1.98% |
| 2026-04-07 | 9.37 | 9.62 | 9.15 | 9.59 | 2.63M | +1.27% |
| 2026-04-06 | 8.98 | 9.68 | 8.98 | 9.47 | 3.39M | +4.99% |
| 2026-04-02 | 9.28 | 9.35 | 8.92 | 9.02 | 7.79M | -3.84% |
| 2026-04-01 | 9.54 | 9.66 | 9.27 | 9.38 | 4.33M | -1.47% |
| 2026-03-31 | 9.57 | 9.69 | 9.30 | 9.52 | 5.61M | +0.74% |
| 2026-03-30 | 9.28 | 9.52 | 9.17 | 9.45 | 2.92M | +1.29% |
| 2026-03-27 | 9.59 | 9.73 | 9.33 | 9.33 | 4.18M | -2.41% |
| 2026-03-26 | 9.19 | 9.69 | 8.89 | 9.56 | 6.15M | +1.70% |
See BCRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCRX — Frequently Asked Questions
Quick answers to the most common questions about buying BCRX stock.
How has BCRX stock performed recently?
BCRX declined -11.7% over the past year, below its 5-year annualized CAGR of -7.5%. The stock trades above its 200-day moving average, reflecting the downtrend.
What is BCRX's all-time high price?
BioCryst Pharmaceuticals, Inc. reached $37.25 on 2000-03-09. The 52-week high is $11.31. Current 1-year return of -11.7% places the stock further from historical peaks.
Where can I download BCRX historical price data?
This page provides BCRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.